Sogroya (somapacitan)

pCPA File Number: 23247
Negotiation Status:
Active Negotiation
Indication(s):
Growth hormone deficiency
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable